Zenas BioPharma Cash Flow Statement (2023-2025) | ZBIO

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income 35.62M-24.78M-27.80M-37.98M-38.61M-56.53M-33.57M-52.22M-51.50M
Depreciation and Depletion 0.03M0.03M0.04M0.04M0.03M0.02M0.01M0.01M
Share-based Compensation 1.00M1.14M0.95M1.54M2.84M5.50M5.39M6.04M7.34M
Gains from Sales and Divestitures 0.01M0.01M
Gains from Investment Securities 6.36M1.00M0.12M0.67M0.62M
Non-cash Items 8.08M79.20M1.29M1.43M3.51M2.83M
Cash from Operations -15.40M-19.10M-30.96M-31.06M-38.55M-37.05M-41.74M-41.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.38M-0.94M-0.19M
Depreciation & Amortization (CF) 0.03M0.03M0.04M0.04M0.03M0.02M0.01M0.01M
Change in Working Capital
Change in Account Payables 3.12M3.41M-0.48M3.39M5.42M2.88M-12.09M-1.95M
Change in Accured Expenses 3.23M1.50M8.68M0.02M11.87M-11.16M16.31M0.10M
Other Working Capital Changes -1.36M-1.79M3.10M-1.79M8.18M0.35M-1.16M1.60M
Investing Activities
Capital Expenditures 0.02M0.04M0.07M0.02M
Change in Acquisitions & Divestments 12.86M14.26M104.24M
Cash from Investing Activities -0.02M-0.04M-26.76M-3.73M-86.27M-112.29M40.04M
Financing Activities
Other financing activities 0.66M0.77M0.44M4.47M
Cash from Financing Activities 0.05M-0.61M177.74M233.98M1.85M0.10M1.72M72.62M
Additional items
Exchange Rate Effect -0.09M0.04M0.03M-0.05M0.14M-0.05M-0.24M0.03M
Change in Cash -15.45M-19.70M146.78M176.11M-40.30M-123.28M-152.55M71.56M
Beginning Cash Balance 72.31M72.31M56.86M37.15M183.93M360.04M437.48M427.45M230.04M
Free Cash Flow -15.40M-19.12M-30.99M-31.06M-38.63M-37.07M-41.74M-41.12M
Net Cash Flow -15.35M-19.74M146.75M176.16M-40.44M-123.23M-152.31M71.53M